Pear Therapeutics Inc
NASDAQ:PEAR
Cash Flow Statement
Cash Flow Statement
Pear Therapeutics Inc
Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | ||
---|---|---|---|---|---|---|
Operating Cash Flow | ||||||
Net Income |
(65)
|
(91)
|
(76)
|
(113)
|
(75)
|
|
Depreciation & Amortization |
2
|
3
|
4
|
5
|
4
|
|
Other Non-Cash Items |
(40)
|
(46)
|
(89)
|
(74)
|
(33)
|
|
Cash Interest Paid |
4
|
5
|
6
|
7
|
4
|
|
Change in Working Capital |
(6)
|
(11)
|
(13)
|
(16)
|
(10)
|
|
Cash from Operating Activities |
(109)
N/A
|
(145)
-33%
|
(174)
-20%
|
(197)
-13%
|
(114)
+42%
|
|
Investing Cash Flow | ||||||
Capital Expenditures |
(5)
|
(5)
|
(6)
|
(7)
|
(3)
|
|
Other Items |
8
|
241
|
242
|
265
|
(6)
|
|
Cash from Investing Activities |
3
N/A
|
235
+8 065%
|
235
0%
|
257
+10%
|
(9)
N/A
|
|
Financing Cash Flow | ||||||
Net Issuance of Common Stock |
21
|
13
|
14
|
14
|
2
|
|
Other |
143
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
164
N/A
|
(113)
N/A
|
(114)
0%
|
(113)
+0%
|
2
N/A
|
|
Change in Cash | ||||||
Net Change in Cash |
58
N/A
|
(23)
N/A
|
(53)
-130%
|
(53)
+0%
|
(121)
-130%
|
|
Free Cash Flow | ||||||
Free Cash Flow |
(114)
N/A
|
(150)
-32%
|
(181)
-20%
|
(204)
-13%
|
(117)
+42%
|